| PDF (649kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-233123
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.23312
Zusammenfassung
Targeting to specific sites of the body via colloidal carriers is sought in order to reduce drug side effects. The adsorption of plasma proteins on intravenously injected particles is regarded as the key factor in explaining their organ distribution: total bound protein, or, more likely, the presence of specific proteins and their conformation, are expected to influence macrophage uptake. ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags